Lymphocytes of dogs immunised with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce IFN gamma resulting in nitric oxide-mediated amastigote apoptosis.
暂无分享,去创建一个
[1] A. Khamesipour,et al. Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran. , 2004, Vaccine.
[2] M. Fuertes,et al. Programmed cell death in trypanosomatids: a way to maximize their biological fitness? , 2004, Trends in parasitology.
[3] A. B. Reis,et al. Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine , 2003, Vaccine.
[4] M. Barcinski,et al. The role of apoptotic mimicry in host-parasite interplay: is death the only alternative for altruistic behavior? , 2003, Kinetoplastid biology and disease.
[5] N. Fasel,et al. Life after death: are trypanosomatids programmed to die for the survival of their partners? , 2003, Kinetoplastid biology and disease.
[6] M. Esteban,et al. Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK. , 2003, Vaccine.
[7] E. Paraguai de Souza,et al. IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis. , 2003, Vaccine.
[8] J. M. Requena,et al. A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum. , 2003, Veterinary immunology and immunopathology.
[9] S. Bertholet,et al. Programmed cell death in trypanosomatids and other unicellular organisms. , 2003, International journal for parasitology.
[10] H. Schild,et al. Apoptosis: the complex scenario for a silent cell death. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.
[11] J. Mottram,et al. Cell death in Leishmania induced by stress and differentiation: programmed cell death or necrosis? , 2002, Cell Death and Differentiation.
[12] E. Paraguai de Souza,et al. Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (São Gonçalo do Amarante, RN). , 2002, Vaccine.
[13] H. Silveira,et al. Cytokine expression during the outcome of canine experimental infection by Leishmania infantum. , 2002, Veterinary immunology and immunopathology.
[14] C. Shaha,et al. Increase in Cytosolic Ca2+ Levels through the Activation of Non-selective Cation Channels Induced by Oxidative Stress Causes Mitochondrial Depolarization Leading to Apoptosis-like Death in Leishmania donovaniPromastigotes* , 2002, The Journal of Biological Chemistry.
[15] D. Sereno,et al. Nitric Oxide-Mediated Proteasome-Dependent Oligonucleosomal DNA Fragmentation in Leishmania amazonensis Amastigotes , 2002, Infection and Immunity.
[16] P. Petit,et al. On the evolution of programmed cell death: apoptosis of the unicellular eukaryote Leishmania major involves cysteine proteinase activation and mitochondrion permeabilization , 2002, Cell Death and Differentiation.
[17] S. Bertholet,et al. Programmed cell death in the unicellular protozoan parasite Leishmania , 2002, Cell Death and Differentiation.
[18] M. Panaro,et al. Nitric oxide production by Leishmania-infected macrophages and modulation by cytokines and prostaglandins. , 2001, Parassitologia.
[19] M. Barcinski,et al. Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity , 2001, Current Biology.
[20] T. Trotta,et al. Inducible nitric oxide synthase expression in Leishmania-infected dog macrophages. , 2001, Comparative immunology, microbiology and infectious diseases.
[21] R. Zamora,et al. The regulatory role of nitric oxide in apoptosis. , 2001, International immunopharmacology.
[22] T. Trotta,et al. Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes. , 2001, Comparative immunology, microbiology and infectious diseases.
[23] D. Sereno,et al. Antimonial-Mediated DNA Fragmentation inLeishmania infantum Amastigotes , 2001, Antimicrobial Agents and Chemotherapy.
[24] J. Nájera. Malaria control: achievements, problems and strategies. , 2001, Parassitologia.
[25] C. Dye,et al. Tissue cytokine responses in canine visceral leishmaniasis. , 2001, The Journal of infectious diseases.
[26] P. Das,et al. Successful Therapy of Lethal Murine Visceral Leishmaniasis with Cystatin Involves Up-Regulation of Nitric Oxide and a Favorable T Cell Response1 , 2001, The Journal of Immunology.
[27] V. Rutten,et al. Infection of a canine macrophage cell line with leishmania infantum: determination of nitric oxide production and anti-leishmanial activity. , 2000, Veterinary parasitology.
[28] H. Majumder,et al. Luteolin, an Abundant Dietary Component is a Potent Anti-leishmanial Agent that Acts by Inducing Topoisomerase II-mediated Kinetoplast DNA Cleavage Leading to Apoptosis , 2000, Molecular medicine.
[29] M. Miles,et al. The strange case of Leishmania chagasi. , 2000, Parasitology today.
[30] C. Jaffe,et al. Immune responses in vaccinated dogs with autoclaved Leishmania major promastigotes. , 1999, Veterinary research.
[31] M. D. Mossalayi,et al. The human immune response during cutaneous leishmaniasis: NO problem. , 1999, Parasitology today.
[32] P. Moore,et al. Compensation for Decreased Expression of B7 Molecules on Leishmania infantum-Infected Canine Macrophages Results in Restoration of Parasite-Specific T-Cell Proliferation and Gamma Interferon Production , 1999, Infection and Immunity.
[33] T. Trotta,et al. Inducible nitric oxide synthase and nitric oxide production inLeishmania infantum-infected human macrophages stimulated with interferon-γ and bacterial lipopolysaccharide , 1999, International journal of clinical & laboratory research.
[34] D. Sereno,et al. Leishmania spp: completely defined medium without serum and macromolecules (CDM/LP) for the continuous in vitro cultivation of infective promastigote forms. , 1999, The American journal of tropical medicine and hygiene.
[35] M. Panaro,et al. Evaluation of nitric oxide production by Leishmania infantum-infected dog macrophages. , 1998, Immunopharmacology and immunotoxicology.
[36] M. Panaro,et al. Evaluation of killing, superoxide anion and nitric oxide production by Leishmania infantum-infected dog monocytes. , 1998, Cytobios.
[37] R Dietze,et al. Effect of eliminating seropositive canines on the transmission of visceral leishmaniasis in Brazil. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[38] P. Debré,et al. Interleukin‐10 and interleukin‐4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation , 1997, European journal of immunology.
[39] A. Berenger,et al. Canine leishmaniasis: identification of asymptomatic carriers by polymerase chain reaction and immunoblotting. , 1996, The American journal of tropical medicine and hygiene.
[40] C. Dye,et al. The logic of visceral leishmaniasis control. , 1996, The American journal of tropical medicine and hygiene.
[41] H. D. del Portillo,et al. Heat shock induction of apoptosis in promastigotes of the unicellular organism Leishmania (Leishmania) amazonensis , 1996, Journal of cellular physiology.
[42] Y. Tselentis,et al. Canine visceral leishmaniasis: successful chemotherapy induces macrophage antileishmanial activity via the L-arginine nitric oxide pathway , 1996, Antimicrobial agents and chemotherapy.
[43] C. Boog,et al. Leishmania infantum‐specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex‐restricted manner , 1995, European journal of immunology.
[44] J. Alvar,et al. Infectivity of dogs naturally infected with Leishmania infantum to colonized Phlebotomus perniciosus. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[45] T. Evans,et al. Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. , 1993, Journal of immunology.
[46] D. Ashford,et al. Studies on the control of visceral leishmaniasis: validation of the Falcon assay screening test--enzyme-linked immunosorbent assay (FAST-ELISA) for field diagnosis of canine visceral leishmaniasis. , 1993, The American journal of tropical medicine and hygiene.
[47] Y. Buchmüller‐Rouiller,et al. Journal of Leukocyte Biology 49:73-82 (1991) Killing of Leishmania Parasites in Activated Murine Macrophages is Based on an L-Arginine-Dependent Process That Produces Nitrogen Derivatives , 2022 .
[48] J. Rioux,et al. Leishmania infantum as a cause of cutaneous leishmaniasis. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[49] M. Meltzer,et al. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. , 1990, Journal of immunology.
[50] M. Gramiccia,et al. Studies on canine leishmaniasis control. 2. Effectiveness of control measures against canine leishmaniasis in the Isle of Elba, Italy. , 1988, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[51] H. Momen,et al. Leishmania infantum, the aetiological agent of American visceral leishmaniasis (AVL)? , 1987, Memorias do Instituto Oswaldo Cruz.
[52] D. Fawcett,et al. Electron microscopy of Leishmania donovani in splenic aspirates from patients with visceral leishmaniasis during treatment with sodium stibogluconate. , 1985, Annals of tropical medicine and parasitology.
[53] J. Berman,et al. Fine-structural alterations in Leishmania tropica within human macrophages exposed to antileishmanial drugs in vitro. , 1983, The Journal of protozoology.
[54] J. Rioux,et al. [Ecology of leishmaniasis in the south of France. 10. Developmental stages and clinical characterization of canine leishmaniasis in relation to epidemiology. (author's transl)]. , 1979, Annales de parasitologie humaine et comparee.